drugset / Trial / NCT04197115
Vitamin C, Thiamine, Cyanocobalamine, Pyridoxine and Hydrocortisone in Sepsis
Non-randomizedSequentialOpen-labelTreatment
Summary
Prospective, experimental, longitudinal cohort study in septic patients treated at ER and ICU at General Hospital Zone 11 IMSS Piedras Negras Coahuila. Interventions, will be implementd in 2 consecutive periods of 6 months Phase 1: 6 months period, septic patients treated only with standard treatment. Phase 2: 6 months period, septic patients treated with Vitamin C, Thiamine, Cyanocobalamine, Pyridoxine and Hydrocortisone + standard treatment.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2020-08-30
- Completion
- 2020-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrocortisone | Other / unclassified | 50 mg | Intravenous |
| Comparator | Pyridoxine | Unknown | 5 mg | Other |
| Comparator | Thiamine | Other / unclassified | 100 mg | Other |
| Comparator | Vitamin B12 | Other / unclassified | 50 ug | Other |
| Comparator | Vitamin C | Other / unclassified | 1.5 g | Intravenous |